Data Storage Corp proposes 275M authorized common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Data Storage Corp. (DTST) is asking shareholders at a December 29, 2026 special meeting to approve raising authorized common shares from 250,000,000 to 275,000,000, increasing the 2021 Plan’s share capacity by 2,000,000 shares, from 2,075,000 to 4,075,000, and allowing the meeting to be adjourned if needed to solicit more votes. The Board recommends voting FOR all three proposals. The authorized-share amendment would take effect only after shareholder approval and if the Board still deems it advisable; the Board may abandon it and says it has no definite plans for the additional shares.
The 2021 Plan had zero shares available for future grants as of September 30, 2026; if approved, the expanded pool is estimated to cover awards through approximately December 2029. Proposed awards include 33,160 RSUs for non-employee directors and conditional PSUs for Chief Executive Officer Charles M. Piluso: 30,000 upon an acquisition of an entity with $3,000,000 in trailing-twelve-month revenue, plus up to 225,000 tied to market-capitalization milestones. The company says the authorized-share increase would not dilute ownership until additional shares are issued; later issuance could dilute ownership and voting rights.
Positive
- None.
Negative
- Minor point. Forward-looking: it has not happened yet and may not happen.The proposed 275,000,000-share authorization could enable future dilution and deter takeovers.
Filing Explained
As of the proxy’s share-count table, 240,954,286 common shares were authorized but unissued and unreserved.
The proxy’s table shows that amount would become 265,954,286 if shareholders approve the charter amendment and the Board implements it; that figure is capacity for future issuance, not shares already issued.
The filing reports that 70,691 RSU awards were issued to non-employee directors on
Key Figures
Key Terms
at-the-market offering program financial
Burn Rate financial
Overhang financial
broker non-vote regulatory
performance share units financial
incentive stock options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What authorized-share increase is DTST proposing?
How much would DTST increase its 2021 Plan share pool?
How could DTST use the additional authorized shares?
What awards could DTST grant if the plan amendment passes?
Can DTST’s Board decide not to implement the authorized-share increase?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☒ Preliminary Proxy Statement
☐ Confidential, For Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))
☐ Definitive Proxy Statement
☐ Definitive Additional Materials
☐ Soliciting Material Pursuant to §240.14a-12
DATA STORAGE CORPORATION
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ No fee required.
☐ Fee paid previously with preliminary materials.
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

November [●], 2026
Dear Fellow Data Storage Corporation Shareholders:
We invite you to attend a Special Meeting of Shareholders (the “Special Meeting”) of Data Storage Corporation to be held at Spaces CocoWalk, 3350 Virginia Street, 2nd Floor, Miami, Florida 33133 on December 29, 2026, at 11:00 a.m. local time.
At the Special Meeting, you will be asked to consider and vote on proposals to: (1) approve an amendment to our Articles of Incorporation, as amended, to increase the number of authorized shares of our common stock, par value $0.001 per share (“Common Stock”), from 250,000,000 shares to 275,000,000 shares; (2) approve an amendment to our 2021 Stock Incentive Plan, as amended and restated, to increase the number of shares of Common Stock available for awards thereunder by 2,000,000 shares, from 2,075,000 shares to 4,075,000 shares; and (3) approve the adjournment of the Special Meeting, if necessary or appropriate, to permit further solicitation and vote of proxies if there are insufficient votes for, or otherwise in connection with, the approval of either of the foregoing proposals.
Your vote is very important regardless of the number of shares that you own. We urge you to read this proxy statement carefully and in its entirety. You may also obtain more information about us from documents we file with the Securities and Exchange Commission from time to time. Whether or not you plan to attend the Special Meeting in person, if you are a holder of record of our shares, please complete, sign, date and return, as promptly as possible, the enclosed proxy card in the accompanying prepaid reply envelope or grant your proxy electronically through the Internet or by telephone. If you attend the Special Meeting and vote in person, your vote will revoke any proxy that you have previously submitted. If you hold your shares in “street name,” you should instruct your broker how to vote in accordance with the voting instruction form you will receive from your bank, broker or other nominee. Accompanying the proxy statement is a proxy card or voting instruction form for the Special Meeting, which you may use to indicate your vote or provide voting instructions, as applicable, as to the proposals contained in this proxy statement.
On behalf of the Board, I thank you for your support and appreciate your consideration of these matters.
Sincerely,
/s/ Charles M. Piluso
Charles M. Piluso
Chief Executive Officer and Chairman of the Board of Directors

244 5th Avenue, Second Floor, Suite 2821
New York, New York 10001
Telephone: (212) 564-4922
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
To the Shareholders of Data Storage Corporation:
A Special Meeting of the Shareholders (the “Special Meeting”) of Data Storage Corporation, a Nevada corporation (together with its subsidiaries, “we”, “us”, “our” or the “Company”), will be held on December 29, 2026, at 11:00 a.m. local time at Spaces CocoWalk, 3350 Virginia Street, 2nd Floor, Miami, Florida 33133. The purpose of the Special Meeting is to consider and act upon the following matters:
| 1. | To approve an amendment to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), to increase the number of authorized shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), from 250,000,000 shares to 275,000,000 shares (the “Authorized Share Increase Proposal” or “Proposal No. 1”); |
| 2. | To approve an amendment to the Company’s 2021 Stock Incentive Plan, as amended and restated (the “2021 Plan”), to increase the number of shares of Common Stock available to grant awards under the 2021 Plan by 2,000,000 shares, from 2,075,000 shares to 4,075,000 shares (the “Plan Amendment Proposal” or “Proposal No. 2”); and |
| 3. | To approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Authorized Share Increase Proposal and/or the Plan Amendment Proposal (the “Adjournment Proposal” or “Proposal No. 3”). |
All shareholders are cordially invited to attend the Special Meeting. Please give the proxy materials your careful attention.
The Board of Directors has fixed the close of business on November 16, 2026, as the record date (the “Record Date”) for determining those shareholders who are entitled to notice of and to vote at the Special Meeting or any adjournment or postponement thereof. The list of the shareholders of record as of the Record Date will be made available for inspection during the ten days preceding the Special Meeting at our offices located at 244 5th Avenue, Second Floor, Suite 2821, New York, New York 10001.
Whether or not you plan to attend the Special Meeting in person, please vote your shares as soon as possible by telephone, via the Internet or by completing, dating, signing and returning the enclosed proxy card in the envelope provided to ensure your shares are voted, or, if you hold your shares in street name, by following the instructions provided by your bank, broker or other financial intermediary. Submitting your proxy now will not prevent you from voting your shares at the Special Meeting if you desire to do so, as your proxy is revocable and voting your shares at the Special Meeting will automatically revoke any prior vote by proxy.
BY ORDER OF THE BOARD OF DIRECTORS
Charles M. Piluso
Chief Executive Officer and Chairman of the Board of Directors
New York, New York
November [●], 2026
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 29, 2026.
The Notice of Special Meeting of Shareholders and
this proxy statement are available at www.proxyvote.com.
TABLE OF CONTENTS
| Page | |
| GENERAL INFORMATION ABOUT THE PROXY STATEMENT AND SPECIAL MEETING | 1 |
| QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING | 2 |
| PROPOSAL NO. 1: APPROVAL OF AN AMENDMENT TO THE ARTICLES OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK | 5 |
| PROPOSAL NO. 2: APPROVAL OF AN AMENDMENT TO THE 2021 STOCK INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE TO GRANT AWARDS BY 2,000,000 SHARES TO 4,075,000 SHARES | 8 |
| PROPOSAL NO. 3: APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES | 14 |
| EXECUTIVE COMPENSATION | 15 |
| DIRECTOR COMPENSATION | 17 |
OTHER INFORMATION |
18 |

244 5th Avenue, Second Floor, Suite 2821
New York, New York 10001
Telephone: (212) 564-4922
PROXY STATEMENT
SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 29, 2026
GENERAL INFORMATION ABOUT THE PROXY STATEMENT AND SPECIAL MEETING
The enclosed proxy statement is furnished to the holders of shares of Common Stock of Data Storage Corporation (“Data Storage,” “we”, “us”, “our” or the “Company”) in connection with the solicitation of proxies by the Board of Directors (the “Board”) for use at the Special Meeting to be held at Spaces CocoWalk, 3350 Virginia Street, 2nd Floor, Miami, Florida 33133, on December 29, 2026, at 11:00 a.m. local time, and at any adjournment or postponement thereof. The Board has fixed the close of business on November 16, 2026, as the record date (the “Record Date”) for determining those shareholders who are entitled to notice of and to vote at the Special Meeting or any adjournment or postponement thereof. Only shareholders as of the Record Date may attend the Special Meeting. The purpose of the Special Meeting and the matters to be acted on are stated in the accompanying Notice of Special Meeting of shareholders.
The Notice of Special Meeting of Shareholders, this proxy statement, and a proxy card are first being mailed to our shareholders on or about November 27, 2026. We will bear the cost of our solicitation of proxies. The original solicitation of proxies by mail may be supplemented by personal interview, telephone, or facsimile by our directors, officers, or employees, who will receive no additional compensation for such services. Arrangements will be made with brokerage houses and other custodians, nominees, and fiduciaries for the forwarding of solicitation material to the beneficial owners of stock held by any such persons, and we will reimburse those custodians, nominees, and fiduciaries for the reasonable out-of-pocket expenses incurred by them in doing so.
The Board of Directors is soliciting votes (1) FOR an amendment to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), to, at the discretion of the Company’s Board of Directors, effect an increase in the number of authorized shares of Common Stock to 275,000,000 shares of Common Stock (the “Authorized Share Increase Proposal” or “Proposal No. 1”); (2) FOR an amendment to the Company’s 2021 Stock Incentive Plan, as amended and restated (the “2021 Plan”), to increase the number of shares of Common Stock available to grant awards under the 2021 Plan by 2,000,000 shares, from 2,075,000 shares to 4,075,000 shares (the “Plan Amendment Proposal” or “Proposal No. 2”); and (3) FOR the adjournment of the Special Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 1 and/or Proposal No. 2 (the “Adjournment Proposal” or “Proposal No. 3”).
Our Board of Directors has fixed the close of business on November 16, 2026 as the record date (the “Record Date”) for determining those shareholders who are entitled to notice of and to vote at the meeting or any adjournment or postponement of the Special Meeting. All shareholders who own shares of Common Stock as of the Record Date are welcome to attend the Special Meeting. If you attend, please note that you will be asked to present government-issued identification (such as a driver’s license or passport) and evidence of your share ownership of our Common Stock on the Record Date. This can be your proxy card if you are a shareholder of record. If your shares are held beneficially in the name of a bank, broker or other holder of record and you plan to attend the Special Meeting, you will be required to present proof of your ownership of our Common Stock on the Record Date, such as a bank or brokerage account statement or voting instruction card, to be admitted to the Special Meeting.
The Board recommends that you vote: (1) FOR the Authorized Share Increase Proposal; (2) FOR the Plan Amendment Proposal; and (3) FOR the Adjournment Proposal.
This proxy statement, the Notice of Special Meeting and the accompanying proxy card will first be mailed to shareholders on or about November 27, 2026. These materials are also available online at www.proxyvote.com.
1
Whether or not you plan to attend the Special Meeting in person, please vote your shares as soon as possible by telephone, via the Internet or by completing, dating, signing and returning the enclosed proxy card in the envelope provided to ensure your shares are voted, or, if you hold your shares in street name, by following the instructions provided by your bank, broker or other financial intermediary. Submitting your proxy now will not prevent you from voting your shares at the Special Meeting if you desire to do so, as your proxy is revocable and voting your shares at the Special Meeting will automatically revoke any prior vote by proxy.
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING
Why am I receiving these materials?
We have sent you these proxy materials because the Board is soliciting your proxy to vote at the Special Meeting. According to our records, you were a holder of shares of our Common Stock as of the end of business on the Record Date. You do not need to attend the Special Meeting to vote your shares.
What is the proxy card?
The proxy card enables you to appoint Charles M. Piluso, our Chief Executive Officer, and Christos (“Chris”) H. Panagiotakos, our Chief Financial Officer, as your representatives at the Special Meeting, with full power of substitution and re-substitution. By completing and returning a proxy card, you are authorizing Mr. Piluso and Mr. Panagiotakos, or either of them, to vote your shares at the Special Meeting in accordance with your instructions on the proxy card. This way, your shares will be voted whether or not you attend the Special Meeting.
When and where is the Special Meeting being held?
The Special Meeting will be held on December 29, 2026, commencing at 11:00 a.m. local time at Spaces CocoWalk, 3350 Virginia Street, 2nd Floor, Miami, Florida 33133.
When were the proxy materials first sent to shareholders?
This proxy statement and the accompanying proxy card will first be mailed to shareholders on or about November 27, 2026.
May I attend the Special Meeting in person?
All shareholders as of the Record Date are welcome to attend the Special Meeting. If you attend, please note that you will be asked to present government-issued identification (such as a driver’s license or passport) and evidence of your share ownership of our Common Stock on the Record Date. Such evidence of ownership can be your proxy card if you are a shareholder of record, or a bank or brokerage account statement or voting instruction form if your shares are held in street name. The Special Meeting will begin promptly at 11:00 a.m., local time, and check-in will begin one-half hour prior to the Special Meeting. Please allow ample time for the check-in procedures.
Be prepared to comply with our security and safety procedures for the Special Meeting, which will include the following: (a) no cameras, computers, recording equipment, other similar electronic devices, signs or placards will be permitted in the Special Meeting; (b) the use of mobile phones, tablets, laptops and similar electronic devices during the Special Meeting is prohibited, and such devices must be turned off and put away before entering the meeting room; and (c) by attending the Special Meeting, shareholders agree to abide by the agenda and procedures for the Special Meeting.
What is the difference between holding shares as a shareholder of record and as a beneficial owner?
If on the Record Date your shares were registered directly in your name with our transfer agent, VStock Transfer LLC, then you are a shareholder of record. If on the Record Date your shares were held in an account at a brokerage firm, bank or other nominee, then you are the beneficial owner of shares held in “street name,” and these proxy materials are being forwarded to you by that organization. If you hold your shares in an account at a brokerage firm, bank or other nominee and wish to vote such shares at the Special Meeting, you must obtain a valid proxy issued in your name from that record holder at least 72 hours prior to the Special Meeting.
2
If you are a beneficial owner and do not instruct your broker how to vote, whether your broker may still vote your shares depends on whether the New York Stock Exchange (the “NYSE”) deems the proposal to be a “routine” matter. Brokers and nominees can use their discretion to vote “uninstructed” shares with respect to matters that are considered to be “routine,” but not with respect to “non-routine” matters. If the broker or nominee that holds your shares does not receive instructions from you on how to vote your shares on a non-routine matter, the organization that holds your shares will not be able to vote your shares on such matter, often referred to as a broker non-vote. Although our Common Stock is listed on The Nasdaq Capital Market (“Nasdaq”), broker discretionary voting is governed by the rules of the NYSE, which apply to member brokerage firms regardless of the exchange on which a company’s securities are listed. Under the rules and interpretations of the NYSE, “non-routine” matters are matters that may substantially affect the rights or privileges of shareholders, such as mergers, shareholder proposals, elections of directors, executive compensation and equity compensation plans, and certain corporate governance proposals, even if management-supported. We believe that Proposal No. 1 (the Authorized Share Increase Proposal) and Proposal No. 3 (the Adjournment Proposal) are routine matters and that Proposal No. 2 (the Plan Amendment Proposal) is a non-routine matter. Accordingly, your broker may vote your shares on Proposal No. 1 and Proposal No. 3 in the absence of your instructions, but may not vote your shares on Proposal No. 2 without your instructions.
What am I voting on?
The following matters are scheduled to be voted on at the Special Meeting:
| 1. | To approve an amendment to the Articles of Incorporation to increase the number of authorized shares of Common Stock from 250,000,000 shares to 275,000,000 shares (Proposal No. 1); |
| 2. | To approve an amendment to the 2021 Plan to increase the number of shares of Common Stock available to grant awards under the 2021 Plan by 2,000,000 shares, from 2,075,000 shares to 4,075,000 shares (Proposal No. 2); and |
| 3. | To approve the adjournment of the Special Meeting, if necessary or appropriate, to permit further solicitation and vote of proxies if there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 1 and/or Proposal No. 2 (Proposal No. 3). |
The Board is not currently aware of any other business that will be brought before the Special Meeting.
How do I vote my shares?
If you are a registered holder, you may vote:
| ● | By Internet. Via the Internet at www.proxyvote.com; |
| ● | By telephone. If you are located within the United States and Canada, call 1-800-690-6903 (toll-free) from a touch-tone telephone or 1-718-921-8500 from foreign countries and follow the instructions; |
| ● | By mail. By returning a properly executed proxy card in the postage-paid envelope provided or to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717; or |
| ● | In person. You may vote in person at the Special Meeting. |
Internet and telephone voting facilities will close at 11:59 p.m. Eastern Time on December 28, 2026 for the voting of shares held by shareholders of record as of the Record Date. To vote online or via telephone, you will need your unique control number, which you can find on your proxy card. Proxy cards with respect to shares held of record must be received no later than December 28, 2026. For each proposal, you may vote “FOR,” “AGAINST” or “ABSTAIN.”
If on the Record Date your shares were held in street name, you will receive voting instructions from your broker, bank or nominee describing the available processes for voting your shares. Shares held in street name may be voted at the Special Meeting only if you obtain a legal proxy from the broker, bank or other nominee giving you the right to vote the shares. If Internet and/or telephone voting are available to a street name holder, such facilities will close at 11:59 p.m. Eastern Time on December 28, 2026. To vote online or via telephone, you will need your unique control number, which you can find on your voting instruction form.
Whether or not you plan to attend the Special Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Special Meeting and vote in person even if you have already voted by proxy. To vote in person, come to the Special Meeting and we will give you a ballot when you arrive.
3
What are the voting requirements to approve each of the proposals?
| Proposal | Vote Required | Voting Options | Effect of Abstentions | Effect of Broker Non-Votes |
| 1. Authorized Share Increase Proposal | Number of votes cast in favor exceeds number of votes cast in opposition | “FOR” “AGAINST” “ABSTAIN” | No effect | No broker non-votes expected; brokers may vote in their discretion |
| 2. Plan Amendment Proposal | Number of votes cast in favor exceeds number of votes cast in opposition | “FOR” “AGAINST” “ABSTAIN” | No effect | No effect |
| 3. Adjournment Proposal | Number of votes cast in favor exceeds number of votes cast in opposition | “FOR” “AGAINST” “ABSTAIN” | No effect | No broker non-votes expected; brokers may vote in their discretion |
How many shares are outstanding and how many votes do I have?
On each matter to be voted upon, you have one vote for each share of Common Stock you hold as of the Record Date. As of the Record Date, 2,427,738 shares of Common Stock were issued and outstanding.
What is a quorum?
The presence in person or by proxy of the holders of thirty-three and one-third percent (33 1/3%) of the outstanding shares of our voting stock is necessary to constitute a quorum at the Special Meeting. Abstentions and broker non-votes are treated as present for purposes of determining whether a quorum exists. Your shares will be counted towards the quorum only if you submit a valid proxy (or, in the case of a beneficial owner, one is submitted on your behalf by your broker, bank or other nominee) or if you attend the Special Meeting in person. In the absence of a quorum, the shareholders so present may, by majority vote, adjourn the Special Meeting until a quorum shall attend.
What if I return a proxy card but do not make specific choices?
If you return a signed and dated proxy card without marking any voting selections, your shares will be voted “FOR” the Authorized Share Increase Proposal (Proposal No. 1) and “FOR” the Plan Amendment Proposal (Proposal No. 2) and “FOR” the Adjournment Proposal (Proposal No. 3).
How does the Board recommend that I vote?
Our Board recommends that you vote your shares “FOR” the Authorized Share Increase Proposal (Proposal No. 1); “FOR” the Plan Amendment Proposal (Proposal No. 2) and “FOR” the Adjournment Proposal (Proposal No. 3).
Who is paying for this proxy solicitation?
We will bear the cost of distributing and soliciting proxies. Proxies may be solicited by mail or personally by our directors, officers or employees, none of whom will receive additional compensation for such solicitation. Those holding shares of record for the benefit of others, or nominee holders, are being asked to distribute proxy soliciting materials to, and request voting instructions from, the beneficial owners of such shares. We will reimburse nominee holders for their reasonable out-of-pocket expenses.
What does it mean if I receive more than one set of proxy materials?
You may receive more than one set of proxy materials, including multiple copies of this proxy statement and multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. If you are a shareholder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date, and return each proxy card and voting instruction card that you receive.
4
I share the same address with another Data Storage Corporation shareholder. Why has our household only received one set of proxy materials?
The rules of the U.S. Securities and Exchange Commission (the “SEC”) permit us to deliver a single set of proxy materials to one address shared by two or more of our shareholders. This practice, known as “householding,” is intended to reduce our printing and postage costs. We have delivered only one set of proxy materials to shareholders who hold their shares through a bank, broker or other holder of record and share a single address, unless we received contrary instructions from any shareholder at that address. Any street name holder residing at the same address who wishes to receive a separate copy of the proxy materials may make such a request by contacting the bank, broker or other holder of record, or Broadridge Financial Solutions, Inc. at (866) 540-7095 or in writing at Broadridge, Householding Department, 51 Mercedes Way, Edgewood, New York 11717.
Can I change or revoke my vote after submitting my proxy?
Yes. If you are the record holder of your shares, you may revoke your proxy at any time before the final vote by (i) submitting another properly completed proxy card with a later date or a later Internet or telephone proxy; (ii) sending a timely written notice of revocation to us at 244 5th Avenue, Second Floor, Suite 2821, New York, New York 10001, Attn: Chief Executive Officer; or (iii) attending the Special Meeting and voting in person. Simply attending the Special Meeting will not, by itself, revoke your proxy. Your last vote is the one that is counted. If your shares are held by your broker or bank, you should follow the instructions provided by your broker or bank.
Who will count the votes?
One or more inspectors of election will tabulate the votes.
Is my vote kept confidential?
Proxy instructions, ballots and voting tabulations that identify individual shareholders are handled in a manner that protects your voting privacy. Your vote will not be disclosed either within our Company or to third parties, except: (i) as necessary to meet applicable legal requirements; (ii) to allow for the tabulation and certification of votes; and (iii) to facilitate a successful proxy solicitation. Occasionally, shareholders provide written comments on their proxy cards, which may be forwarded to our management and the Board.
How can I find out the results of the voting?
Preliminary voting results will be announced at the Special Meeting. Final voting results will be disclosed in a Current Report on Form 8-K filed within four business days after the Special Meeting.
Do I have dissenters’ rights?
No. Under Nevada law, our shareholders are not entitled to dissenters’ rights with respect to the matters to be voted on at the Special Meeting, and we will not independently provide our shareholders with any such right.
PROPOSAL NO. 1: APPROVAL OF AN AMENDMENT TO THE ARTICLES OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK
The Board has adopted a resolution approving and recommending to our shareholders for their approval a proposed amendment to our Articles of Incorporation to effect an increase in the number of shares of our authorized Common Stock from the 250,000,000 shares that are currently authorized for issuance pursuant to our Articles of Incorporation to a total of 275,000,000 shares of Common Stock (the “Authorized Share Increase”). The number of authorized shares of our preferred stock, par value $0.001 per share (the “Preferred Stock”), will remain at 10,000,000 shares. Such amendment will be effected after shareholder approval only in the event the Board still deems it advisable. The text of the form of the proposed certificate of amendment to the Articles of Incorporation to implement the Authorized Share Increase is set forth in Annex A to this proxy statement (the “Charter Amendment”).
Assuming the shareholders approve the Authorized Share Increase Proposal and the Board still deems it advisable, the Authorized Share Increase will be effected upon the filing of the Charter Amendment with the Secretary of State of the State of Nevada. The Board will implement the Authorized Share Increase at such time, if ever, as it deems advisable and in the best interests of the Company and its shareholders, and the Board will have the discretion to abandon the Authorized Share Increase if it does not believe it to be in the best interests of the Company and its shareholders. If the Board does not implement the Authorized Share Increase prior to the one-year anniversary of the Special Meeting, the Board will again seek shareholder approval before implementing any increase in our authorized shares of Common Stock.
5
The Company currently has 260,000,000 authorized shares of capital stock, consisting of 250,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock. Of our 250,000,000 shares of currently authorized Common Stock, 2,427,738 shares were outstanding as of the Record Date and 5,625,129 shares were held as treasury stock. After taking into account (i) shares underlying outstanding warrants, stock options and unvested restricted stock units, and (ii) the reservation of shares for future issuance under the 2021 Plan, approximately 240,954,286 of the 250,000,000 shares authorized under our Articles of Incorporation would be available for issuance. The chart below illustrates the number of shares of Common Stock that will be available for issuance if the Authorized Share Increase is effected.
| Estimated number of shares of Common Stock before the Authorized Share Increase | Estimated number of shares of Common Stock after the Authorized Share Increase | |||||||
| Authorized | 250,000,000 | 275,000,000 | ||||||
| Issued and Outstanding | 2,427,738 | 2,427,738 | ||||||
| Held as Treasury Stock | 5,625,129 | 5,625,129 | ||||||
| Issuable under Outstanding Warrants | 172,500 | 172,500 | ||||||
| Issuable under Outstanding Stock Options | 613,656 | 613,656 | ||||||
| Issuable under Outstanding Unvested Restricted Stock Units | 206,691 | 206,691 | ||||||
| Reserved for Future Issuance under the 2021 Plan (1) | 0 | 0 | ||||||
| Authorized but Unissued and Unreserved(2) | 240,954,286 | 265,954,286 | ||||||
(1) Shares reserved for future issuance under the 2021 Plan, excluding shares issuable under outstanding stock options and unvested restricted stock units, and excluding the additional shares that would become available if Proposal No. 2 is approved.
(2) Shares authorized but unissued and unreserved represent shares of Common Stock available for future issuance beyond shares currently outstanding, shares held in treasury, shares issuable under outstanding warrants, stock options and unvested restricted stock units, and shares reserved for issuance under our 2021 Plan.
Reasons for the Authorized Share Increase
The Board believes that the Authorized Share Increase is advisable and in our best interest and the best interest of our shareholders. The increase will provide us with flexibility in completing financing and capital raising transactions, including sales under our at-the-market offering program with Maxim Group LLC, which may be necessary for us to execute our future business plans. Other possible business and financial uses for the additional shares of Common Stock include, without limitation, attracting and retaining employees by the issuance of additional securities, and other transactions and corporate purposes that the Board may deem are in our best interest.
We could also use the additional shares of Common Stock for potential strategic transactions, including, among other things, acquisitions of one or more revenue-generating businesses, including potentially by means of a merger in which the Company’s public listing and balance sheet serve as the platform for a combined enterprise, as well as strategic partnerships, joint ventures, restructurings, business combinations and investments. We believe that the additional authorized shares of Common Stock would enable us to act quickly in response to opportunities that may arise for these types of transactions, in most cases without the necessity of obtaining further shareholder approval and holding a special shareholders’ meeting before such issuance(s) could proceed, except as provided under Nevada law or under applicable Nasdaq rules.
As of the date of this proxy statement, we have no definite plans, proposals or arrangements regarding the newly authorized shares of Common Stock. However, we review and evaluate potential capital raising activities, transactions and other corporate actions on an ongoing basis to determine if such actions would be in our best interest and the best interest of our shareholders.
6
Effects of the Authorized Share Increase
The additional shares of Common Stock to be authorized would have rights identical to our currently outstanding Common Stock. Holders of our Common Stock do not have preemptive rights. The Authorized Share Increase would not have any dilutive effect on the proportionate voting power or other rights of existing shareholders until additional shares are issued. As is true for shares presently authorized but unissued, the future issuance of Common Stock authorized by the Authorized Share Increase may, among other things, decrease existing shareholders’ percentage equity ownership, could be dilutive to the voting rights of existing shareholders and, depending on the price at which the shares are issued, could have a negative effect on the market price of the Common Stock.
Potential Anti-takeover Effects of the Authorized Share Increase
Release No. 34-15230 of the staff of the SEC requires disclosure and discussion of the effects of any action, including the proposals discussed herein, that may be used as an anti-takeover mechanism. If effected, the Authorized Share Increase will result in an increase in the number of authorized but unissued shares of our Common Stock which could, under certain circumstances, have an anti-takeover effect, although this is not the purpose or intent of the Board. We have not proposed the Authorized Share Increase with the intention of using the additional authorized shares for anti-takeover purposes.
An increase in our authorized shares could potentially deter takeovers, including takeovers that the Board has determined are not in the best interest of our shareholders, in that additional shares could be issued (within the limits imposed by applicable law) in one or more transactions that could make a change in control or takeover more difficult. For example, we could issue additional shares so as to dilute the stock ownership or voting rights of persons seeking to obtain control of the Company without our agreement. Similarly, the issuance of additional shares to certain persons allied with our management could have the effect of making it more difficult to remove our current management by diluting the stock ownership or voting rights of persons seeking to cause such removal. The Authorized Share Increase may therefore have the effect of discouraging unsolicited takeover attempts and, by doing so, may limit the opportunity for our shareholders to dispose of their shares at the higher price generally available in takeover attempts or that may be available under a merger proposal.
Although the Authorized Share Increase has been prompted by business and financial considerations and not by the threat of any known or threatened hostile takeover attempt, shareholders should be aware that the Authorized Share Increase could facilitate future attempts by us to oppose changes in control of the Company and perpetuate our management, including transactions in which the shareholders might otherwise receive a premium for their shares over then-current market prices.
Interests of Directors and Executive Officers
Our directors and executive officers do not have any substantial interest, direct or indirect, in the Authorized Share Increase Proposal, other than their interests as holders of Common Stock and outstanding equity awards exercisable for or settleable in Common Stock.
Vote Required
Approval of the Authorized Share Increase Proposal requires that the number of votes cast in favor of the proposal exceed the number of votes cast in opposition. Abstentions will have no effect on the outcome of this proposal. Because this proposal is a routine matter on which brokers may vote in their discretion if not directed how to vote, broker non-votes are not expected for this proposal.
Recommendation of our Board
THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” THE APPROVAL OF THE AUTHORIZED SHARE INCREASE PROPOSAL.
7
PROPOSAL NO. 2: APPROVAL OF AN AMENDMENT TO THE 2021 STOCK INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE TO GRANT AWARDS BY 2,000,000 SHARES TO 4,075,000 SHARES
On November 17, 2026, the Board approved, subject to shareholder approval, an amendment to the 2021 Plan, a copy of which is attached to this proxy statement as Annex B, to increase the maximum number of shares of Common Stock available to grant awards under the 2021 Plan by 2,000,000 shares to 4,075,000 shares (the “Plan Amendment”).
Currently, the maximum number of shares of Common Stock available for issuance under the 2021 Plan is 2,075,000 shares. As of September 30, 2026, there were 0 shares available for future grants under the 2021 Plan, and 613,656 stock options and 206,691 unvested restricted stock units (“RSUs”) were outstanding under our equity incentive plans. As of the Record Date, 2,427,738 shares of Common Stock are issued and outstanding. On November 16, 2026, the closing sale price of our Common Stock on Nasdaq was $2.6139 per share.
Since the adoption of the 2021 Plan, we have granted the maximum number of awards available for issuance thereunder. A substantial portion of those awards resulted in the issuance of shares of Common Stock upon the settlement of vested RSUs or the exercise of stock options, which were subsequently tendered by their holders and repurchased by us in our tender offer completed in January 2026. Such repurchased shares are no longer outstanding and are currently held as treasury stock. Under the terms of the 2021 Plan, shares repurchased by us in the tender offer are not added back to the share reserve available for future awards.
We face intense competition in recruiting high-quality personnel and in retaining our employees. The Board continues to believe that stock-based incentives are important factors in attracting, retaining and rewarding officers, employees, directors and consultants and closely aligning their interests with those of our shareholders. There are currently a minimal number of shares available for issuance under the 2021 Plan, which will hinder our compensation structure and strategy, and is insufficient to grant even our full 2026 annual non-employee directors grants as well as the performance stock units (“PSUs”) contemplated by the amended employment agreement entered into on February 13, 2026 with our Chief Executive Officer (together with the amended employment agreement entered into on the same date with our Chief Financial Officer, the “Amended Employment Agreements”), which vest only upon the achievement of market capitalization milestones or the completion of qualifying acquisitions, and the potential need to recruit additional executive talent as we evaluate our strategic alternatives. The Board believes that increasing the number of shares available for issuance under the 2021 Plan is consistent with our compensation philosophy (and with responsible compensation policies generally) and will preserve our ability to attract and retain capable officers, employees, directors and consultants. In addition to our nine directors (which include our Chief Executive Officer), approximately seven employees and approximately six key consultants are eligible to participate in the 2021 Plan.
If our shareholders do not approve this Proposal No. 2, the Plan Amendment will not become effective, and we will not have any awards available for grants under the 2021 Plan. In that event, the Compensation Committee may be required to make awards in cash or other forms of compensation, or to make awards subject to future shareholder approval. We estimate that, if this Proposal No. 2 is approved, the shares available under the 2021 Plan will be sufficient to cover awards through approximately December 2029. We are seeking shareholder approval of the Plan Amendment to satisfy the shareholder approval requirements of Nasdaq Listing Rule 5635(c), to increase the number of shares authorized to be issued pursuant to the 2021 Plan and to permit options granted under the 2021 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended.
Purpose of the 2021 Plan
The Board believes that the 2021 Plan, with the Plan Amendment, is necessary for us to attract, retain and motivate our employees, directors and consultants through the grant of stock options, stock appreciation rights, restricted stock, restricted stock units and other equity-based or equity-related awards. We believe the 2021 Plan is best designed to provide the proper incentives for our employees, directors and consultants, ensures our ability to make performance-based awards, and meets the requirements of applicable law.
Share Usage and Key Data
We manage our long-term shareholder dilution by limiting the number of equity incentive awards granted annually. The Compensation Committee monitors our annual stock award Burn Rate and Overhang (each as defined below), among other factors, in its efforts to maximize shareholders’ value by granting what, in the Compensation Committee’s judgment, are the appropriate number of equity incentive awards necessary to attract, reward, and retain employees, non-employee directors and consultants. The table below illustrates our Burn Rate and Overhang under the 2021 Plan for the past three fiscal years.
8
| 2025 | 2024 | 2023 | |||||||||||
| Burn Rate(1) | 2.4 | % | 3.9 | % | 8.4 | % | |||||||
| Overhang(2) | 12.9 | % | 16.5 | % | 15.8 | % | |||||||
(1) Burn Rate is (number of shares subject to equity awards granted during a fiscal year)/(total common shares outstanding for that fiscal year).
(2) Overhang is (number of shares subject to outstanding awards at the end of a fiscal year + number of shares available for new awards under incentive plan)/(number of shares subject to outstanding awards at the end of the fiscal year + number of shares available for new awards under incentive plan + total common shares outstanding for that fiscal year).
Summary of the 2021 Stock Incentive Plan
The following is a summary of the principal features of the 2021 Plan. This summary does not purport to be a complete description of all of the provisions of the 2021 Plan and it is qualified in its entirety by reference to the full text of the 2021 Plan, a copy of which is annexed as an exhibit to our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
Available Shares. An aggregate of 2,075,000 shares of Common Stock may currently be issued under the 2021 Plan, which number will increase to 4,075,000 if this Proposal No. 2 is approved, subject to equitable adjustment in the event of future stock splits and other capital changes, all of which may be issued in respect of Incentive Stock Options (or ISOs) that meet the requirements of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). In applying the aggregate share limitation under the 2021 Plan, shares of Common Stock (i) subject to awards that are forfeited, cancelled, returned to the Company for failure to satisfy vesting requirements or otherwise forfeited, or terminated without payment being made thereunder and (ii) that are surrendered in payment or partial payment of the exercise price of an option or taxes required to be withheld with respect to the exercise of stock options or in payment with respect to any other form of award are not counted and, therefore, may be made subject to new awards under the 2021 Plan.
Administration. The 2021 Plan is administered by the Compensation Committee. The Compensation Committee has discretion to determine the individuals to whom awards may be granted under the 2021 Plan, the number of shares of Common Stock, units or other rights subject to each award, the type of award, the manner in which such awards will vest, and the other conditions applicable to awards. The Compensation Committee is authorized to interpret the 2021 Plan, to prescribe, amend and rescind any rules and regulations relating to the 2021 Plan and to make any other determinations necessary or desirable for the administration of the 2021 Plan. All interpretations, determinations and actions by the Compensation Committee are final, conclusive and binding on all parties.
Eligibility. Any employee, officer, director, consultant, advisor or other individual service provider of the Company or any of its subsidiaries, or any person who is determined by the Compensation Committee to be a prospective employee, officer, director, consultant, advisor or other individual service provider of the Company or any of its subsidiaries, is eligible to participate in the 2021 Plan. As awards under the 2021 Plan are within the discretion of the Compensation Committee, we cannot determine how many individuals in each of the categories described above will receive awards.
Types of Awards. Under the 2021 Plan, the Compensation Committee may grant nonqualified stock options (or NSOs), ISOs, stock appreciation rights (or SARs), restricted stock, stock units, performance shares, performance units, other cash-based awards and other stock-based awards. The terms of each award will be set forth in a written agreement with the recipient.
Stock Options. The Compensation Committee will determine the exercise price and other terms for each option and whether the options will be NSOs or ISOs. The exercise price per share of each option will not be less than 100% of the Fair Market Value (as defined in the 2021 Plan) of the Common Stock on the date of grant (or 110% of the Fair Market Value per share in the case of ISOs granted to a ten-percent or more shareholder). However, if permissible under applicable law and the rules of the exchange on which the Company is listed, options to participants who are not residents of the U.S. may be granted at a price below Fair Market Value on the date of grant. ISOs may be granted only to employees and are subject to certain other restrictions. To the extent an option intended to be an ISO does not qualify as an ISO, it will be treated as a nonqualified option.
9
A participant may exercise an option by written notice and payment of the exercise price in cash, or, as determined by the Compensation Committee, through delivery of previously owned shares, the withholding of shares deliverable upon exercise, a cashless exercise program implemented by the Compensation Committee in connection with the 2021 Plan, and/or such other method as approved by the Compensation Committee and set forth in an award agreement. The maximum term of any option granted under the 2021 Plan is ten years from the date of grant (five years in the case of an ISO granted to a ten-percent or more shareholder). No employee may receive ISOs that first become exercisable in any calendar year in an amount exceeding $100,000.
Unless an award agreement provides otherwise, if a participant’s Service (as defined in the 2021 Plan) terminates (i) by reason of his or her death or Disability (as defined in the 2021 Plan), any option held by such participant may be exercised, to the extent otherwise exercisable, by the participant or his or her estate or personal representative, as applicable, for up to one year after the date of such death or termination of Service, (ii) for Cause (as defined in the 2021 Plan), any option held by such participant will be forfeited and cancelled as of the date of termination of Service and (iii) for any reason other than death, Disability or Cause, any option held by such participant may be exercised, to the extent otherwise exercisable, up until ninety (90) days following termination of Service.
Stock Appreciation Rights. The Compensation Committee may grant SARs independent of or in connection with an option. The base price per share of each SAR will not be less than 100% of the Fair Market Value of a share of Common Stock on the date of grant. The maximum term of any SAR granted under the 2021 Plan will be ten years from the date of grant. Generally, each SAR will entitle a participant upon exercise to an amount equal to the excess of the Fair Market Value on the exercise date of one share of Common Stock over the base price of the SAR, multiplied by the number of shares of Common Stock as to which the SAR is exercised. Payment may be made in shares of Common Stock, in cash, or partly in each, as determined by the Compensation Committee.
Restricted Stock and Stock Units. The Compensation Committee may award restricted Common Stock and/or stock units under the 2021 Plan. Restricted stock awards consist of shares of stock that are transferred to a participant subject to restrictions that may result in forfeiture if specified conditions are not satisfied. Stock units confer the right to receive shares of Common Stock, cash, or a combination of shares and cash, at a future date upon or following the attainment of certain conditions specified by the Compensation Committee, subject to applicable tax withholding requirements. The Compensation Committee will determine the restrictions and conditions applicable to each award of restricted stock or stock units, which may include performance-based conditions. Unless the Compensation Committee determines otherwise at the time of grant, holders of restricted stock will have the right to vote the shares and receive all dividends and other distributions.
Performance Shares and Performance Units. The Compensation Committee may award performance shares and/or performance units under the 2021 Plan. Performance shares and performance units are awards, payable in shares of Common Stock, cash or a combination thereof, which are earned during a specified time period subject to the attainment of performance goals, as established by the Compensation Committee.
Incentive Bonus Awards. The Compensation Committee may award incentive bonus awards payable in cash or shares of Common Stock, as set forth in an award agreement. Incentive bonus awards may be based upon the attainment of specified levels of Company or subsidiary performance, as measured by pre-established, objective performance criteria determined at the discretion of the Compensation Committee. The amount of an incentive bonus award to be paid upon the attainment of each targeted level of performance will equal a percentage of a participant’s base salary for the fiscal year, a fixed dollar amount, or such other formula, as determined by the Compensation Committee.
Other Stock-Based and Cash-Based Awards. The Compensation Committee may award other types of stock-based or cash-based awards under the 2021 Plan, including the grant or offer for sale of unrestricted shares of Common Stock, in such amounts and subject to such terms and conditions as the Compensation Committee determines.
Transferability. Awards granted under the 2021 Plan will not be transferable other than by will or by the laws of descent and distribution, except that the Compensation Committee may permit NSOs, share-settled SARs, restricted stock, performance shares or share-settled other stock-based awards to be transferred to members of the participant’s immediate family, to an inter vivos or testamentary trust in which such awards are to be passed to the participant’s designated beneficiaries, or by gift to charitable institutions.
10
Change in Control. The Compensation Committee may, at the time of the grant of an award, provide for the effect of a Change in Control (as defined in the 2021 Plan) on any award, including (i) accelerating or extending the time periods for exercising, vesting in, or realizing gain from any award, (ii) eliminating or modifying the performance or other conditions related to the payment or other rights under an award, (iii) providing for the cash settlement of an award for an equivalent cash value, or (iv) such other modification or adjustment to an award as the Compensation Committee deems appropriate. Unless otherwise provided by an award agreement, the Compensation Committee may also, without the consent of any recipient, take one or more of the following actions contingent upon a Change in Control: (a) cause any or all outstanding options and SARs to become vested and immediately exercisable, in whole or in part; (b) cause any other awards to become non-forfeitable, in whole or in part; (c) cancel any option or SAR in exchange for a substitute option and/or SAR; (d) cancel any award of restricted stock, stock units, performance shares or performance units in exchange for a similar award of the capital stock of any successor corporation; (e) redeem any restricted stock for cash and/or other substitute consideration with a value equal to the Fair Market Value of an unrestricted share of Common Stock on the date of the Change in Control; or (f) terminate any award in exchange for an amount of cash and/or property equal to the amount, if any, that would have been attained upon the exercise of such award or realization of the participant’s rights as of the date of the Change in Control (the “Change in Control Consideration”); provided that if the Change in Control Consideration with respect to any option or SAR does not exceed its exercise price, the Compensation Committee may cancel the option or SAR without payment.
Term; Amendment and Termination. The 2021 Plan will continue in effect until terminated by the Board; provided, however, that no award will be granted under the 2021 Plan on or after the 10th anniversary of the date of the adoption of the 2021 Plan by the Board, and awards granted prior to such date may extend beyond that date. The Board may suspend, terminate or amend the 2021 Plan at any time, provided that (i) no amendment, suspension or termination may materially impair any rights or materially increase any obligations under any awards previously granted without the consent of the affected participant, (ii) the Company shall obtain shareholder approval of any 2021 Plan amendment as required to comply with any applicable law, regulation or stock exchange rule and (iii) shareholder approval is required for any amendment to the 2021 Plan that (x) increases the number of shares of Common Stock available for issuance thereunder or (y) changes the persons or class of persons eligible to receive awards.
New Plan Benefits
Awards under the 2021 Plan are made at the discretion of the Compensation Committee, and, as of the date of this proxy statement, we are unable to determine the number of awards that will be granted under the 2021 Plan in the future, except as described below. If this Proposal No. 2 is approved, we intend to grant (i) an aggregate of 33,160 RSUs to our non-employee directors, allocated pro rata among them, to fulfill compensation obligations for 2026 that were not fulfilled due to the lack of available shares under the 2021 Plan, (ii) if earned, 30,000 vested PSUs to Mr. Piluso pursuant to the Amended Piluso Employment Agreement upon our consummation of the acquisition of an entity that has $3,000,000 in TTM revenue; and (iii) if earned, three grants of 75,000 PSUs (up to an aggregate of 225,000 PSUs) pursuant to the Amended Piluso Employment Agreement that vest upon our market capitalization reaching each of $30 million, $60 million and $90 million for twenty trading days. The following table sets forth these awards.
11
| Name and Position | Dollar Value ($)(1) | Number of Units | ||||||
| Charles M. Piluso, Chief Executive Officer and Chairman | $ | 666,545 | 255,000 | (2) | ||||
| Chris H. Panagiotakos, Chief Financial Officer and Treasurer | — | — | ||||||
| Harold J. Schwartz, Former President | — | — | ||||||
| All Current Executive Officers as a Group | $ | 666,545 | 255,000 | (2) | ||||
| All Current Non-Executive Directors as a Group | $ | 86,677 | 33,160 | (3) | ||||
| All Current Non-Executive Officer Employees as a Group | — | — | ||||||
(1) Based on $2.6139, the closing sale price of our Common Stock on Nasdaq on November 16, 2026, assuming for purposes of this proxy statement only, that the performance conditions of the PSUs were met by Mr. Piluso on such date, and that the PSUs and RSUs were granted to Mr. Piluso and each of the eight current non-employee directors, respectively, on such date. The grant date fair value of the awards set forth in the table above is computed in accordance with FASB ASC Topic 718.
(2) 30,000 PSUs to be granted to Mr. Piluso upon our consummation of the acquisition of an entity that has $3,000,000 in TTM revenue and three grants of 75,000 PSUs (up to an aggregate of 225,000 PSUs) to be granted upon our market capitalization reaching each of $30 million, $60 million and $90 million for twenty trading days. They will be fully vested when granted. No such acquisition has been consummated, nor has our market capitalization reached $30 million (or more) for twenty trading days, and these PSUs will not be granted unless any such performance targets are met.
(3) 4,145 RSUs to be granted to each of our eight current non-employee directors, if this Proposal No. 2 is approved.
Interests of Directors and Executive Officers
Our current directors and executive officers have substantial interests in the matters set forth in this proposal since equity awards may be granted to them under the 2021 Plan.
Material United States Federal Income Tax Consequences
The following is a brief description of the principal federal income tax consequences, as of the date of this proxy statement, associated with the grant of awards under the 2021 Plan. This summary is based on our understanding of present United States federal income tax law and regulations. The summary does not purport to be complete or applicable to every specific situation, and it does not address foreign, state or local tax consequences.
Options. There is generally no United States federal income tax consequence to the participant solely by reason of the grant of incentive stock options or nonqualified stock options under the 2021 Plan, assuming the exercise price of the option is not less than the fair market value of the shares on the date of grant. If certain requirements are satisfied, including the requirement that the participant generally must exercise the incentive stock option no later than three months following the termination of the participant’s employment with us, the exercise of an incentive stock option is not a taxable event for regular federal income tax purposes, although such exercise may give rise to alternative minimum tax liability. Upon the exercise of a nonqualified stock option, the participant will generally recognize ordinary income in an amount equal to the excess of the fair market value of the shares at the time of exercise over the exercise price, which will be subject to wage and employment tax withholding, and we generally will be entitled to a corresponding deduction.
12
Dispositions of Option Shares. If a participant disposes of shares acquired upon exercise of an incentive stock option more than two years from the date of grant and more than one year after the date of exercise, the participant will realize long-term capital gain or loss equal to the difference between the amount realized and the exercise price. If the participant disposes of such shares before those holding periods are met (a “disqualifying disposition”), the participant will generally recognize ordinary income equal to the lesser of (i) the excess of the fair market value of the shares on the date of exercise over the exercise price or (ii) the participant’s actual gain, and any additional gain will be capital gain. Upon a disposition of shares acquired upon exercise of a nonqualified stock option, the participant will recognize capital gain or loss equal to the difference between the participant’s basis in the shares and the amount realized.
Alternative Minimum Tax. For alternative minimum tax purposes, the spread upon exercise of an incentive stock option (but not a nonqualified stock option) will be included in alternative minimum taxable income, and the taxpayer will receive a tax basis equal to the fair market value of the shares at such time for subsequent alternative minimum tax purposes.
Stock Appreciation Rights. There are generally no tax consequences to the participant or us by reason of the grant of SARs. Upon exercise, the participant will recognize taxable ordinary income equal to the amount payable, and, subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation, we generally will be entitled to a corresponding deduction.
Restricted Stock and RSUs. Unless a participant makes a Section 83(b) election, a participant receiving restricted stock will not recognize ordinary income until the award vests, at which time the excess of the fair market value of the shares over the amount paid, if any, will be ordinary income to the participant and deductible by us. If the participant files a Section 83(b) election within 30 days after the date of grant, the participant’s ordinary income and holding period, and our deduction, will be determined as of the date of grant. A participant receiving RSUs generally will recognize ordinary income when the shares or cash are delivered in settlement of the award.
Section 409A. If an award under the 2021 Plan is subject to Section 409A of the Code but does not comply with its requirements, the taxable events described above could apply earlier than described and could result in the imposition of additional taxes, interest and penalties.
Potential Limitation on Company Deductions. Section 162(m) of the Code generally disallows a tax deduction for compensation in excess of $1 million paid in a taxable year by a publicly held corporation to its chief executive officer and certain other “covered employees.” Our Board and Compensation Committee intend to consider the potential impact of Section 162(m) on grants made under the 2021 Plan but reserve the right to approve grants that exceed the deduction limit.
Equity Compensation Plan Information
The following table provides information as of December 31, 2025 with respect to our equity compensation plans, consisting of the Amended and Restated Data Storage Corporation Incentive Award Plan (the “2010 Plan”), which expired on October 21, 2020, and the 2021 Plan:
| Plan Category | Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) | Weighted-average exercise price of outstanding options, warrants and rights (b) | Number of securities remaining available for future issuance (excluding securities in column (a)) (c) | |||||||||
| Equity compensation plans approved by security holders: 2010 Plan | 6,250 | $ | 5.20 | — | ||||||||
| Equity compensation plans approved by security holders: 2021 Plan | 217,406 | $ | 3.14 | 857,291 | ||||||||
| Equity compensation plans not approved by security holders | N/A | N/A | N/A | |||||||||
| Total | 223,656 | $ | 3.20 | 857,291 | ||||||||
Vote Required
Approval of the Plan Amendment Proposal requires that the number of votes cast in favor of the proposal exceed the number of votes cast in opposition. Abstentions and broker non-votes will have no effect on the outcome of this proposal.
Recommendation of our Board
THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” THE APPROVAL OF THE AMENDMENT TO THE COMPANY’S 2021 STOCK INCENTIVE PLAN.
13
PROPOSAL NO. 3: APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES
We are asking our shareholders to approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Authorized Share Increase Proposal and/or the Plan Amendment Proposal (the “Adjournment Proposal”). If our shareholders approve the Adjournment Proposal, we could adjourn the Special Meeting and use the additional time to solicit additional proxies, including proxies from shareholders who have previously voted against Proposal No. 1 and/or Proposal No. 2.
If the Special Meeting is adjourned, shareholders who have already submitted their proxies will be able to revoke them at any time prior to their use at the reconvened meeting. If the Special Meeting is adjourned to a later date, notice of the adjourned meeting need not be given if the date, time and place thereof are announced at the Special Meeting, unless a new record date is fixed for the adjourned meeting or as otherwise required by Nevada law or our bylaws, as amended (the “Bylaws”). The Board will determine whether to adjourn the Special Meeting only if it is necessary or appropriate to do so, and the Board will not adjourn the Special Meeting if Proposal No. 1 and Proposal No. 2 have each received sufficient votes for approval.
Among other things, approval of the Adjournment Proposal could mean that, even if we had received proxies representing a sufficient number of votes against Proposal No. 1 and/or Proposal No. 2 to defeat such proposal, we could adjourn the Special Meeting without a vote on such proposal(s) and seek to convince the holders of those shares to change their votes in favor of such proposal(s).
Interests of Directors and Executive Officers
Our directors and executive officers do not have any substantial interest, direct or indirect, in the Adjournment Proposal, other than to the extent of their interests in Proposal No. 1 and/or Proposal No. 2 described above.
Vote Required
Approval of the Adjournment Proposal requires that the number of votes cast in favor of the proposal exceed the number of votes cast in opposition. Abstentions will have no effect on the outcome of this proposal. Because this proposal is a routine matter on which brokers may vote in their discretion if not directed how to vote, broker non-votes are not expected for this proposal.
Recommendation of our Board
THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR”
THE APPROVAL OF THE
ADJOURNMENT PROPOSAL.
14
EXECUTIVE COMPENSATION
The following summary compensation table sets forth all compensation awarded to, earned by, or paid to our named executive officers during the fiscal years ended December 31, 2025 and December 31, 2024.
| Name & Principal Position | Year | Salary | Bonus | Stock Awards(1) | Option Awards(1) | All Other Comp.(2) | Total | |||||||||||||||||||||
| Charles M. Piluso, CEO and Chairman | 2025 | $ | 250,000 | $ | 250,000 | $ | 97,375 | $ | 31,084 | $ | 19,306 | $ | 647,765 | |||||||||||||||
| 2024 | $ | 250,000 | $ | 200,000 | $ | 50,000 | $ | 34,907 | $ | 17,298 | $ | 552,205 | ||||||||||||||||
| Harold J. Schwartz, Former President(3) | 2025 | $ | 171,000 | $ | 121,301 | — | — | $ | 23,319 | $ | 315,620 | |||||||||||||||||
| 2024 | $ | 245,000 | $ | 175,000 | $ | 50,000 | $ | 34,907 | $ | 27,368 | $ | 532,275 | ||||||||||||||||
| Chris H. Panagiotakos, CFO and Treasurer | 2025 | $ | 235,000 | $ | 208,750 | $ | 29,375 | $ | 29,374 | $ | 60 | $ | 502,559 | |||||||||||||||
| 2024 | $ | 235,000 | $ | 100,625 | $ | 53,052 | $ | 52,967 | $ | 9,073 | $ | 450,717 | ||||||||||||||||
(1) We follow the requirements of FASB ASC 718-10-10, Share-Based Payments, with regard to stock-based compensation issued to employees and non-employees. Please see Note 2 to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Annual Report”) for more information regarding the valuation assumptions used in determining such amounts. These amounts do not correspond to the actual value that may be realized upon vesting or exercise of such awards.
(2) All other compensation consists of the employer portion of health insurance and 401(k) match.
(3) Mr. Schwartz only received salary payments until September 11, 2025, when the CloudFirst business was sold, although he did not officially resign as our President until February 12, 2026. Mr. Schwartz resigned from our Board on November 4, 2026. He is included in this table because he was a named executive officer for fiscal year 2025.
Executive Employment Agreements
Mr. Piluso’s Employment Agreement
On March 28, 2023, we entered into an employment agreement, as amended (the “Piluso Employment Agreement”), with Mr. Charles M. Piluso, our Chief Executive Officer. Mr. Piluso received an annual base salary of $250,000 for 2024 and 2025 and was eligible to earn a performance bonus ranging from $75,000 to $300,000. Mr. Piluso was also entitled to an equity award with a total value of $100,000 per annum, split equally between RSUs and stock options. Pursuant to the Piluso Employment Agreement, Mr. Piluso was also entitled to an equity award of 75,000 performance share units, one-third of which would vest upon our market capitalization reaching each of $35,000,000, $50,000,000 and $75,000,000 for at least twenty trading days. The $35,000,000 target was achieved by September 28, 2024, and, at Mr. Piluso’s request, 12,500 RSUs were granted to him and 12,500 RSUs to Mr. Schwartz in place of those units. One-third of the units were forfeited on March 28, 2026, and the remaining 25,000 units will be forfeited if the $75,000,000 target is not achieved by September 28, 2027.
On February 13, 2026, we and Mr. Piluso entered into an amendment to the Piluso Employment Agreement (the “Amended Piluso Employment Agreement”), effective as of January 1, 2026, for an initial term of three years that automatically extends for successive one-year terms unless either party gives 90 days’ written notice of non-renewal. Mr. Piluso’s annual base salary is $275,000. Upon execution, Mr. Piluso received stock options to purchase up to 250,000 shares of Common Stock and 60,000 RSUs under the 2021 Plan, vesting one-third on each of May 20, 2027, May 20, 2028 and May 20, 2029. Upon our consummation of the acquisition of an entity that has $3,000,000 in trailing twelve months (“TTM”) revenue, Mr. Piluso will receive 30,000 vested PSUs, and he will receive three grants of 75,000 PSUs (up to an aggregate of 225,000 PSUs) that vest upon our market capitalization reaching each of $30 million, $60 million and $90 million for twenty trading days. Mr. Piluso is also eligible for (i) an annual cash bonus ranging from 0% to 200% of his base salary, with a target of 100%; (ii) a one-time cash bonus of $100,000 for each completed acquisition of an entity that has $3,000,000 in TTM revenue; and (iii) a one-time cash bonus of $250,000 upon the completion of a reverse merger.
15
Mr. Panagiotakos’ Employment Agreement
On March 28, 2023, we entered into an employment agreement, as amended (the “Panagiotakos Employment Agreement”), with Mr. Chris H. Panagiotakos, our Chief Financial Officer. Mr. Panagiotakos received an annual base salary of $235,000 for 2024 and 2025 and was eligible to earn a performance bonus of 25% of his base salary, an annual equity award equal to 25% of his base salary split equally between RSUs and stock options, a financial achievement bonus of $45,000 and a long-term incentive bonus of stock options and RSUs equal to 25% of his base salary.
On February 13, 2026, we and Mr. Panagiotakos entered into an amendment to the Panagiotakos Employment Agreement (as amended, the “Amended Panagiotakos Employment Agreement”), effective as of January 1, 2026, for an initial term of three years that automatically extends for successive one-year terms unless either party gives 90 days’ written notice of non-renewal. Mr. Panagiotakos’ annual base salary is $270,000. Upon execution, Mr. Panagiotakos received stock options to purchase up to 125,000 shares of Common Stock and 60,000 RSUs under the 2021 Plan, vesting one-third on each of May 20, 2027, May 20, 2028 and May 20, 2029. Mr. Panagiotakos is eligible for an annual cash bonus ranging from 0% to 200% of his base salary, with a target of 50%.
Termination and Change in Control
If the employment of Mr. Piluso or Mr. Panagiotakos (each, an “Executive”) is terminated by us for Cause (as defined in the applicable Amended Employment Agreement), we are only required to pay the Executive his base salary and accrued vacation through the last day of employment, and all non-vested equity awards are forfeited. If the Executive is terminated due to death or disability or resigns without Good Reason (as defined in the applicable Amended Employment Agreement), we must pay the Executive, in a single lump sum, his base salary and accrued vacation through the last day of employment and a pro rata portion of his annual target bonus for the year of termination, and, in the case of death or disability, all outstanding equity awards vest immediately. If, before the end of the initial term, the Executive is terminated by us without Cause (and not due to death or disability) or resigns for Good Reason, he is entitled to his base salary for the remainder of the initial term, acceleration of all outstanding equity awards, and a one-time severance payment equal to one times his base salary plus a pro rata portion of his last annual cash bonus. If such a termination occurs within 24 months after a Change in Control (as defined in the applicable Amended Employment Agreement), the Executive is entitled to his base salary for the remainder of the initial term, acceleration of all outstanding equity awards, and a one-time lump sum severance payment equal to one times his base salary plus his last annual cash bonus, whether or not the initial term has expired. All severance payments are conditioned on the Executive’s execution of a general release.
Other Employment Arrangements
We did not have a formal employment agreement with Mr. Schwartz. His salary was determined by the Compensation Committee and evaluated annually; his annual base salary was $245,000 for 2024 and 2025. He was eligible to earn RSUs and stock options, in addition to a cash bonus determined by the Compensation Committee.
Outstanding Equity Awards at Fiscal Year-End
The following table sets forth information concerning the shares of Common Stock underlying outstanding equity awards held by each of our named executive officers as of December 31, 2025.
| Name | Grant Date | Options Exercisable (#) | Options Unexercisable (#) | Exercise Price ($) | Expiration Date | Unvested Shares or Units (#) | ||||||||||||||||||
| Charles M. Piluso(1) | 3/1/2023 | 29,412 | — | $ | 1.96 | 2/28/2028 | — | |||||||||||||||||
| 3/28/2023 | 28,249 | — | $ | 1.77 | 3/27/2028 | — | ||||||||||||||||||
| 1/2/2024 | 15,528 | — | $ | 3.22 | 1/2/2029 | — | ||||||||||||||||||
| 1/17/2025 | 13,748 | — | $ | 4.59 | 1/17/2030 | — | ||||||||||||||||||
| Harold J. Schwartz(2) | — | — | — | — | — | — | ||||||||||||||||||
| Chris H. Panagiotakos(1) | 3/1/2023 | 14,706 | — | $ | 1.78 | 2/28/2033 | — | |||||||||||||||||
| 3/28/2023 | 16,693 | — | $ | 1.61 | 3/27/2033 | — | ||||||||||||||||||
| 1/2/2024 | 19,198 | — | $ | 2.93 | 1/2/2034 | — | ||||||||||||||||||
| 1/17/2025 | 8,019 | — | $ | 4.18 | 1/17/2035 | — | ||||||||||||||||||
(1) These option awards vested 33.33% on each of the first three anniversaries of the grant date. As of September 11, 2025, all options were fully vested. The table does not include the stock options and RSUs granted to Mr. Piluso and Mr. Panagiotakos on February 13, 2026 under the Amended Employment Agreements, which are described above.
(2) Mr. Schwartz did not have any outstanding equity awards as of December 31, 2025.
16
DIRECTOR COMPENSATION
The following table sets forth all compensation awarded to, earned by, or paid to our non-employee directors, and directors who were employees but not named executive officers, during the fiscal year ended December 31, 2025.
| Director Name | Fees Earned or Paid in Cash | Stock Awards(1) | All Other Compensation | Total | ||||||||||||
| Thomas C. Kempster | — | — | $ | 256,602 | (2) | $ | 256,602 | |||||||||
| Lawrence A. Maglione, Jr. | $ | 7,500 | $ | 29,998 | — | $ | 37,498 | |||||||||
| John Argen | $ | 7,500 | $ | 29,998 | — | $ | 37,498 | |||||||||
| Matthew Grover | $ | 7,500 | $ | 29,998 | — | $ | 37,498 | |||||||||
| Todd A. Correll | $ | 7,500 | $ | 29,998 | — | $ | 37,498 | |||||||||
| Clifford Stein | $ | 7,500 | $ | 29,998 | — | $ | 37,498 | |||||||||
| Nancy M. Stallone | $ | 7,500 | $ | 29,998 | — | $ | 37,498 | |||||||||
| Uwayne A. Mitchell | $ | 7,500 | $ | 29,998 | — | $ | 37,498 | |||||||||
(1) Computed in accordance with FASB ASC 718-10-10. See Note 2 to the Consolidated Financial Statements included in the 2025 Annual Report. These amounts do not correspond to the actual value that may be realized upon vesting of such awards.
(2) Includes $164,678 and $69,315 earned as salary and bonus, respectively, and $22,609 consisting of the Company’s portion of health insurance and 401(k) match, earned by Mr. Kempster as our Executive Vice President before his resignation as an executive officer in September 2025.
As of December 31, 2025, our non-employee directors held outstanding options to purchase the following numbers of shares of Common Stock: Mr. Kempster, 28,764; Mr. Argen, 5,000; Mr. Correll, 5,000; Mr. Grover, 5,000; Mr. Maglione, 5,000; Mr. Stein, 5,000; Ms. Stallone, 3,333; and Mr. Mitchell, 3,333.
On September 2, 2026, the Board granted an aggregate of 108,000 RSUs to the then current non-employee directors under the 2021 Plan. Prior to issuing the RSUs and entering into the award agreements with the directors, because a portion of those grants exceeded the number of shares then available for issuance under the 2021 Plan, on November 11, 2026, the Board approved the rescission of an aggregate of 37,309 RSUs, such rescissions to be apportioned pro rata among the directors, resulting in the issuance of an aggregate of 70,691 RSUs to our non-employee directors on September 2, 2026. If this Proposal No. 2 is approved, we intend to issue an aggregate of 33,160 RSUs to our current eight non-employee directors.
17
OTHER INFORMATION
Notice Regarding Delivery of Shareholder Documents
(“Householding” Information)
The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements by delivering a single copy of these materials to an address shared by two or more of our shareholders. This process, which is commonly referred to as “householding,” potentially means extra convenience for shareholders and cost savings for companies and intermediaries. A number of brokers and other intermediaries with account holders who are our shareholders may be householding our shareholder materials, including this proxy statement. In that event, a single proxy statement will be delivered to multiple shareholders sharing an address unless contrary instructions have been received from the affected shareholders. Once you have received notice from your broker or other intermediary that it will be householding communications to your address, householding will continue until you are notified otherwise or until you revoke your consent, which is deemed to be given unless you inform the broker or other intermediary otherwise when you receive or received the original notice of householding. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement, please notify your broker or other intermediary to discontinue householding and direct your written request to receive a separate proxy statement to us at: Data Storage Corporation, 244 5th Avenue, Second Floor, Suite 2821, New York, New York 10001, Attention: Corporate Secretary, or by calling us at (212) 564-4922. Shareholders who currently receive multiple copies of the proxy statement at their address and would like to request householding of their communications should contact their broker or other intermediary.
SHAREHOLDER PROPOSALS FOR THE 2027 ANNUAL MEETING
Shareholders who intend to present proposals for inclusion in our proxy materials for the 2027 Annual Meeting of Shareholders (the “2027 Annual Meeting”) under SEC Rule 14a-8 must ensure that such proposals are received by our Corporate Secretary in writing at Data Storage Corporation, 244 5th Avenue, Second Floor, Suite 2821, New York, New York 10001, not later than March 18, 2027. If you wish to submit a proposal (including a director nomination) at the 2027 Annual Meeting, you must comply with all applicable requirements of Rule 14a-8 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) for inclusion in our 2027 proxy materials.
In addition to satisfying the foregoing requirements, to comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than our nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than July 4, 2027. If the date of the 2027 Annual Meeting is changed by more than 30 days from the anniversary of our 2026 Annual Meeting of Shareholders (the “2026 Annual Meeting”), then notice must be provided by the later of 60 calendar days prior to the date of the 2027 Annual Meeting or the 10th calendar day following the day on which public announcement of the date of the 2027 Annual Meeting is first made.
OTHER MATTERS
As of the date of this proxy statement, the Board knows of no other matters to be presented for shareholder action at the Special Meeting.
By Order of the Board of Directors,
/s/ Charles M. Piluso
Charles M. Piluso
Chief Executive Officer and Chairman of the Board of Directors
18
ANNEX A
FORM OF CERTIFICATE OF AMENDMENT TO THE ARTICLES
OF INCORPORATION OF DATA
STORAGE CORPORATION
(Pursuant to NRS 78.385 and 78.390)
| 1. | Name of corporation: Data Storage Corporation. |
| 2. | The articles have been amended as follows: The first sentence of Article 3 of the Articles of Incorporation of the Corporation, as amended, is hereby amended and restated in its entirety to read as follows:
Article 3. Shares. The total number of shares of capital stock which the Corporation shall have authority to issue is 285,000,000 shares, consisting of 275,000,000 shares of common stock, par value $0.001 per share (“Common Stock”), and 10,000,000 shares of preferred stock, par value $0.001 per share (“Preferred Stock”). |
| 3. | The vote by which the stockholders have approved the amendment pursuant to NRS 78.390(1)(a)(1) is: [●] votes for and [●] votes against. The number of votes cast in favor of the amendment exceeded the number of votes cast against it. |
| 4. | Effective date and time of filing: Upon filing. |
| 5. | Signature of officer: |
_______________________________
Name: Charles M. Piluso
Title: Chief Executive Officer
19
ANNEX B
AMENDMENT NO. 2 TO THE DATA STORAGE CORPORATION
2021 STOCK INCENTIVE PLAN,
AS AMENDED AND RESTATED
WHEREAS, the Board of Directors (the “Board”) of Data Storage Corporation (the “Company”) heretofore established the Data Storage Corporation 2021 Stock Incentive Plan, as amended and restated (the “Plan”);
WHEREAS, the Board desires to amend the Plan to increase the maximum number of shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), available for issuance under the Plan by 2,000,000 shares, from 2,075,000 shares to 4,075,000 shares (this “Amendment”);
WHEREAS, the Plan authorizes the Board to amend the Plan, subject to shareholder approval to the extent required by applicable law, regulation or stock exchange rule, and the Plan requires shareholder approval of any amendment that increases the number of shares of Common Stock available for issuance thereunder; and
WHEREAS, the Board has approved and authorized this Amendment and has recommended that the shareholders of the Company approve this Amendment.
NOW, THEREFORE, subject to and effective upon receipt of the required approval of the Company’s shareholders, the Plan is hereby amended as follows:
| 1. | Section 4.1(a) of the Plan is hereby amended by deleting the number “2,075,000” and replacing it with “4,075,000”. |
| 2. | Except as specifically set forth herein, the terms of the Plan shall be and remain unchanged, and the Plan, as amended, shall remain in full force and effect. |
IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its duly authorized officer as of December [●], 2026.
| DATA STORAGE CORPORATION | ||
| By: | ||
| Name: | Charles M. Piluso | |
| Title: | Chief Executive Officer | |
20
